Anthony Chin
Obstetrics & Gynecology · Beverly Hills, CANPI 1649315375
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $588 and has fallen 56.9% since, to $254 in 2024.
Across 92 payments — averaging $21.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ascend Therapeutics US, LLC$250
- Mayne Pharma Commercial LLC$177
- AbbVie$173
- Exeltis, USA Inc.$169
- Therapeuticsmd, Inc.$169
- Pfizer$158
- plus $876 from 18 others
What the payments were for
- Food & beverage$1,88596%
- Education$874%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ascend Therapeutics US, LLC | 13 | $250 |
| Mayne Pharma Commercial LLC | 7 | $177 |
| AbbVie(2 entities) | 9 | $173 |
| Exeltis, USA Inc. | 3 | $169 |
| Therapeuticsmd, Inc. | 10 | $169 |
| Pfizer | 7 | $158 |
| Astellas Pharma US Inc | 6 | $119 |
| Vertical Pharmaceuticals, LLC | 8 | $116 |
| AMAG Pharmaceuticals, Inc. | 4 | $87 |
| Shield Therapeutics Inc | 3 | $84 |
| Exact Sciences | 3 | $63 |
| Myovant Sciences Inc. | 3 | $62 |
| Bayer | 2 | $46 |
| Avion Pharmaceuticals | 2 | $40 |
| Coopersurgical, Inc. | 1 | $34 |
| Lupin Inc. | 2 | $33 |
| IBSA Pharma Inc. | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Duchesnay USA Incorporated | 1 | $25 |
| Roche Diagnostics Corporation | 1 | $25 |
| Amgen | 1 | $24 |
| Evofem Biosciences, Inc. | 1 | $22 |
| Medicem Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Slynd$122
How this compares
$1,972 in reported general payments places this provider in the 75th percentile of 3,784 obstetrics & gynecology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 12 | $1,328 |
| ProgesteroneProgesterone, Micronized | 22 | $419 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Beverly Hills
- Steve YuNorthridge$964K
- Samir HageRedlands$640K
- Malcolm MunroLos Angeles$609K
- Michael KrychmanCosta Mesa$547K
- Anita NelsonTorrance$530K
- Jan SegnitzSan Jose$511K
- Risa KaganBerkeley$497K
- Michael GreenOxnard$424K
- Howard SalvaySanta Cruz$421K
- Marc WinterLaguna Hills$399K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.